Merck & Company Inc

Healthcare · Drug Manufacturers - General

147.20$ +1.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Merck & Company Inc (MRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 64,926 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MRK
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	19,829	23,637	26,898	32,714	40,363	21,199	21,446	22,486	22,973	22,012	22,636	24,198	23,850	27,428	45,987	48,047	47,267	44,033	42,237	39,498	39,807	40,122	42,294	39,121	41,518	48,704	59,283	60,115	64,168	64,926
Cost of Revenue	8,588	10,953	13,175	16,389	21,166	3,625	3,907	4,437	4,966	5,150	6,001	6,141	5,583	9,019	18,396	16,871	16,446	16,954	16,768	14,934	14,030	12,912	13,509	12,016	13,618	13,626	17,411	16,126	15,193	18,195
Gross Profit	11,240	12,684	13,724	16,325	19,197	17,574	17,539	18,049	18,007	16,862	16,635	18,057	18,267	18,409	27,591	31,176	30,821	27,079	25,469	24,564	25,777	27,210	28,785	27,105	27,900	35,078	41,872	43,989	48,975	46,731
Research & Development	1,487	1,684	1,821	2,068	2,344	2,456	2,677	3,280	4,010	3,848	4,783	4,883	4,805	5,845	11,111	8,467	8,168	7,503	7,180	6,704	10,261	10,339	9,752	9,724	13,397	12,245	13,548	30,531	17,938	12,514
Selling, General & Administrative	3,841	4,299	4,511	5,200	6,168	6,224	6,187	6,395	7,346	7,156	8,165	7,557	7,377	8,543	13,245	13,733	12,776	11,911	11,606	10,313	255	244	8,002	8,715	6,769	7,403	7,469	7,584	7,700	10,610
Total Operating Expenses	6,256	6,820	7,348	8,730	10,108	8,296	8,449	9,480	11,249	11,004	12,948	12,440	12,182	14,388	24,236	22,200	20,944	19,414	18,786	17,017	20,278	20,413	19,854	19,179	22,352	21,879	23,590	41,035	28,754	23,245
Operating Income	4,985	5,864	6,376	7,594	9,089	9,278	9,089	8,569	6,758	5,859	3,687	5,618	6,085	4,021	3,355	8,976	9,877	7,665	6,683	7,547	5,499	6,797	8,931	7,926	5,548	13,199	18,282	2,954	20,221	23,486
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	251	458	715	749	714	801	732	672	693	754	772	893	831	806	962	1,146	1,271	1,357
Pre-Tax Income	5,541	6,462	8,133	8,620	9,824	9,948	9,652	9,052	8,003	7,364	6,221	3,371	9,931	15,290	1,653	7,334	8,739	5,545	17,283	5,401	4,659	6,521	8,701	7,171	5,863	13,879	16,444	1,889	19,936	21,067
Income Tax Expense	1,660	1,848	2,885	2,729	3,002	2,895	2,857	2,462	2,173	2,733	1,788	95	1,999	2,268	671	942	2,440	1,028	5,349	942	718	4,103	2,508	1,565	1,340	1,521	1,918	1,512	2,803	2,804
Net Income	3,881	4,614	5,248	5,891	6,822	7,282	7,150	6,831	5,830	4,631	4,434	3,275	7,808	12,899	861	6,272	6,168	4,404	11,920	4,442	3,920	2,394	6,220	9,843	7,067	13,049	14,519	365	17,117	18,254
EBITDA	5,912	6,701	7,391	9,056	10,686	10,411	10,321	9,883	8,209	7,567	5,955	7,606	11,813	18,326	9,749	15,456	16,431	13,334	24,706	12,448	10,823	11,951	13,992	11,374	10,180	17,899	21,315	6,907	25,706	28,262

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings